Dr. Shah Discusses Ongoing Research With CAR T-Cell Therapy

Video

Nirav N. Shah, MD, assistant professor, Medical College of Wisconsin, discusses ongoing research with CAR T-cell therapy.

Nirav N. Shah, MD, assistant professor, Medical College of Wisconsin, discusses ongoing research with CAR T-cell therapy.

There are many studies evaluating future applications of CAR T cells and other cellular therapies, Shah says. There are armored CAR T cells being studied; these differ from the products currently on the market and may prove to be more effective, says Shah. In addition, ongoing research is looking at dual-targeted CAR T cells as well as sequential CAR T-cell therapy.

Moreover, some institutions are studying the role of a different type of immune effector cell called an NK cell. CAR NK is a construct that researchers hope is on the rise as another potential option for patients who have failed traditional treatments, Shah adds.

Related Videos
George Tachas, PhD
Alexandra Gomez-Arteaga, MD
Pietro Genovese, PhD, the principal investigator at the Gene Therapy Program of Dana-Farber/Boston Children’s Cancer and Blood Disorder Center
Akshay Sharma, MBBS, a bone marrow transplant physician at St. Jude Children’s Research Hospital
M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level
Caspian Oliai, MD, MS, the medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Frederick “Eric” Arnold, PhD
Genovefa (Zenia) Papanicolaou, MD, an infectious diseases specialist at Memorial Sloan Kettering Cancer Center
Jeffrey Chamberlain, PhD, on Exciting New Research at MDA 2024
Alan Beggs, PhD, on Challenges in Therapeutic Development for Rare Diseases
© 2024 MJH Life Sciences

All rights reserved.